莫苏尼图祖马布和淋巴瘤:2022年ASH年度会议的最新更新
Yang Cao1, Emanuela C Marcucci2, Lihua E Budde3
1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Journal of hematology & oncology
|June 28, 2023
概括
一种新的双特异性抗体 (BsAb) - - 莫苏内图祖马布 (Mosunetuzumab) - - 为复发性或耐火性毛囊性淋巴瘤提供了一种新的免疫疗法选择. 这种抗CD20/抗CD3疗法在以前用全身疗法治疗的患者中显示出高响应率.
科学领域:
- 免疫治疗是一种免疫疗法.
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 双特异性抗体 (BsAbs) 是一种针对血液性恶性瘤的新型免疫疗法.
- 莫苏内图祖马布是第一个被批准用于淋巴瘤治疗的双特异性抗体.
- 它分别针对恶性B细胞和T细胞的CD20和CD3抗原.
研究的目的:
- 为了提供关于淋巴瘤中mosunetuzumab的最新临床数据的概述.
- 突出莫苏内图祖马布在复发或耐火性卵泡淋巴瘤患者的疗效和安全性.
主要方法:
- 所提供的数据来自国际,多中心,第二阶段临床试验.
- 被纳入的患者在至少两次先前的全身治疗后复发或耐药的卵泡淋巴瘤 (R/R FL).
主要成果:
- 在R/RFL患者中,莫苏内图祖马布的整体响应率 (ORR) 高达80%.
- 观察到60%的完整响应率 (CR),表明有效性显著.
- 这些数据在2022年美国血液学会 (ASH) 年会上发表.
结论:
- 莫苏内图祖马布是复发性或耐火性毛囊性淋巴瘤患者的有效治疗选择.
- 它的批准标志着对淋巴瘤的基于双特异抗体的免疫疗法的重大进展.
- 需要在临床实践中进一步评估mosunetuzumab.
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Cancer Vaccines
433
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
433
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


